Combination of gemcitabine and docetaxel: A regimen overestimated in refractory metastatic osteosarcoma?

The combination of gemcitabine and docetaxel (GT) has been demonstrated to be effective against various types of solid tumors, including sarcoma. However, the regimen has not been confirmed in large, welldesigned clinical trials in refractory metastatic osteosarcoma.